Andere Sprachen Imunon, Inc.

Aktien

A3DWEJ

US15117N6022

IMNN

Verzögert Nasdaq Andere Börsenplätze 19:31:35 30.04.2024			% 5 Tage	% 1. Jan.
1,28 ^USD	-5,52 %		-3,76 %	+88,24 %

18.04.	Imunon, Inc. Antrag für den Beginn von Humantests für IMNN-101 genehmigt	CI
01.04.	IMUNON, INC. : Bewertung von HC Wainwright kaufen	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine	18.04.
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine	18.04.
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101	18.04.
Imunon, Inc. Application Cleared to Begin Human Testing of IMNN-101	18.04.
IMUNON Reports Compliance with Nasdaq Listing Requirements	11.04.
Top Midday Gainers	28.03.
Imunon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
IMUNON Reports 2023 Financial Results and Provides Business Update	28.03.
North American Morning Briefing : Stocks Set for -2-	28.03.
IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses	25.03.
IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024	21.03.
IMUNON Files IND Application to Begin Human Testing of IMNN-101	13.03.
Imunon, Inc. Files Ind Application to Begin Human Testing of Imnn-101	13.03.
IMUNON Names Executive Chairman as Temporary Head Following Resignation of CEO Corinne Le Goff	13.03.
IMUNON Announces Leadership Change	12.03.
Imunon, Inc. Announces Executive Changes	12.03.
Imunon, Inc. Announces Resignation of Corinne Le Goff as Chief Executive Officer, Effective March 15, 2024	12.03.
Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5	29.02.
Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer	27.02.
IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Imunon, Inc.

Aktien

A3DWEJ

US15117N6022

IMNN

Andere Sprachen

Filter